CClinicalTrials.gg
RecruitingNCT07100561HeFRAUpdated Sep 10, 2026

30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital

An interventional study of Extensive post discharge counselling and phone-based follow up in Heart Failure, sponsored by Komfo Anokye Teaching Hospital. Recruiting at 1 site in Ghana. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Komfo Anokye Teaching Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure readmission
  • phone-based follow up
  • extensive post discharge counseling
  • pilot randomized control trial
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • Adults Aged 18 years and above

      • Diagnosed with heart failure
      • NYHA Class II-IV
      • Informed consent

Exclusion criteria

Exclusion Criteria:

    • NHYA class I

      • Patients who do not have access to a mobile phone
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • No intervention
    control/Usual Care

    The usual care (counselling by their attending physicians and their normal outpatient reviews).

  • Experimental
    intervention arm

    Other: Extensive post discharge counselling and phone-based follow up

Interventions

  • OtherExtensive post discharge counselling and phone-based follow up

    Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.

05

What researchers measure

Primary outcomes

  1. the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization

    the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization

    Time frame: 90 days

Secondary outcomes

  1. 1. Readmission rate of heart failure patients on guideline-directed heart failure medications

    The readmission rate of heart failure patients on guideline-directed medical therapy (GDMT) will be compared to those who are not on GDMT.

    Time frame: 90days

  2. Quality of life of the heart failure patients at 90 days

    Quality of life at 90 days will be measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).

    Time frame: 90days

  3. All-cause mortality within 30 and 90 days

    . Assessing all-cause mortality will involve tracking total deaths from any reason within a population over the 90-day follow-up

    Time frame: 90 days

  4. Caregiver burden in heart failure management

    Caregiver burden will be assessed using the standard tool "Caregiver Burden Questionnaire - Heart Failure Version 3.0 (CBQ-HF)

    Time frame: 30 days

06

Study locations

1 of 1 sites recruiting
  • Komfo Anokye Teaching Hospital
    Kumasi, Ashanti Region, Ghana
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07100561
Lead sponsor
Komfo Anokye Teaching Hospital
Responsible party
Sponsor
First posted
Aug 3, 2025
Start date
Jul 14, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 10, 2026

Study contacts

SOLOMON GYABAAH
Contact
solomongyabaah53@gmail.com
+233265763129

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion